Literature DB >> 12766082

Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization.

Eiji Sakurai1, Hogara Taguchi, Akshay Anand, Balamurali K Ambati, Evangelos S Gragoudas, Joan W Miller, Anthony P Adamis, Jayakrishna Ambati.   

Abstract

PURPOSE: To investigate the role of the leukocyte adhesion molecules CD18 and intercellular adhesion molecule (ICAM)-1 in the development of choroidal neovascularization (CNV).
METHODS: Laser photocoagulation was used to induce CNV in wild-type C57BL/6J mice and species-specific counterparts with targeted homozygous disruption of the CD18 or ICAM-1 gene. Expression of CD18 and ICAM-1 after laser injury was assessed by immunostaining. CNV responses were compared on the basis of en masse volumetric measurements obtained by confocal microscopy 2 weeks after laser injury and by determination of fluorescein angiographic leakage at 1, 2, and 4 weeks after laser injury.
RESULTS: The site of laser injury showed upregulation of ICAM-1 and invasion by CD18-positive leukocytes within 1 day of laser injury. Significantly fewer lesions exhibited fluorescein leakage defined to be pathologically significant in CD18-deficient mice at weeks 1, 2, and 4 weeks and in ICAM-1-deficient mice at 1 and 4 weeks, compared with the control. There were a significantly greater number of lesions without fluorescein leakage in CD18-deficient mice than in the other two groups at all time points. The volume of CNV in CD18- and ICAM-1-deficient mice was significantly less than in wild type.
CONCLUSIONS: These data suggest a nonredundant role for leukocyte adhesion to vascular endothelium in the development of laser-induced choroidal neovascularization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766082     DOI: 10.1167/iovs.02-1246

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  42 in total

Review 1.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

Review 2.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

3.  Clinical validation of a link between TNF-alpha and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopathy.

Authors:  B M Ben-Mahmud; W H Chan; R M Abdulahad; A Datti; A Orlacchio; E M Kohner; R Chibber
Journal:  Diabetologia       Date:  2006-07-11       Impact factor: 10.122

4.  Intravitreal injection of (99)Tc-MDP inhibits the development of laser-induced choroidal neovascularization in rhesus monkeys.

Authors:  Kunbei Lai; Chenjin Jin; Shu Tu; Yunfan Xiong; Rui Huang; Jian Ge
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-05       Impact factor: 3.117

Review 5.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

6.  Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells.

Authors:  Jessica M Skeie; John H Fingert; Stephen R Russell; Edwin M Stone; Robert F Mullins
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-19       Impact factor: 4.799

7.  Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration.

Authors:  Chikako Yoshizawa; Wataru Saito; Shigeki Hirose; Hirokuni Kitamei; Kousuke Noda; Susumu Ishida
Journal:  Jpn J Ophthalmol       Date:  2012-10-24       Impact factor: 2.447

Review 8.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

9.  Anti-SPARC oligopeptide inhibits laser-induced CNV in mice.

Authors:  Hironori Uehara; Ling Luo; Jacquelyn Simonis; Nirbhai Singh; Ethan Will Taylor; Balamurali K Ambati
Journal:  Vision Res       Date:  2009-12-22       Impact factor: 1.886

10.  CCR3 is a target for age-related macular degeneration diagnosis and therapy.

Authors:  Atsunobu Takeda; Judit Z Baffi; Mark E Kleinman; Won Gil Cho; Miho Nozaki; Kiyoshi Yamada; Hiroki Kaneko; Romulo J C Albuquerque; Sami Dridi; Kuniharu Saito; Brian J Raisler; Steven J Budd; Pete Geisen; Ariel Munitz; Balamurali K Ambati; Martha G Green; Tatsuro Ishibashi; John D Wright; Alison A Humbles; Craig J Gerard; Yuichiro Ogura; Yuzhen Pan; Justine R Smith; Salvatore Grisanti; M Elizabeth Hartnett; Marc E Rothenberg; Jayakrishna Ambati
Journal:  Nature       Date:  2009-06-14       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.